Universal Health Servs Analyst Ratings
Universal Health Servs Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/14/2023 | 16.89% | Cantor Fitzgerald | → $148 | Reiterates | Underweight → Underweight |
07/27/2023 | 33.48% | Credit Suisse | $163 → $169 | Maintains | Outperform |
07/26/2023 | 22.42% | Stephens & Co. | → $155 | Reiterates | Equal-Weight → Equal-Weight |
07/11/2023 | 34.27% | Mizuho | $150 → $170 | Maintains | Buy |
06/02/2023 | 28.74% | B of A Securities | → $163 | Assumes | Neutral → Buy |
05/16/2023 | 9.79% | Goldman Sachs | $124 → $139 | Maintains | Sell |
05/16/2023 | 18.47% | Mizuho | $140 → $150 | Maintains | Buy |
05/08/2023 | 21.63% | TD Cowen | $138 → $154 | Maintains | Market Perform |
04/27/2023 | 30.32% | Citigroup | $150 → $165 | Maintains | Buy |
04/27/2023 | 14.52% | Stephens & Co. | $140 → $145 | Maintains | Equal-Weight |
04/27/2023 | 22.42% | Deutsche Bank | $145 → $155 | Maintains | Buy |
04/27/2023 | 20.05% | RBC Capital | $130 → $152 | Maintains | Sector Perform |
04/27/2023 | 28.74% | Credit Suisse | $153 → $163 | Maintains | Outperform |
04/25/2023 | 12.16% | Barclays | $132 → $142 | Upgrades | Underweight → Equal-Weight |
04/21/2023 | 12.95% | Cantor Fitzgerald | → $143 | Initiates Coverage On | → Underweight |
04/19/2023 | 5.05% | JP Morgan | → $133 | Initiates Coverage On | → Neutral |
03/06/2023 | 14.52% | Deutsche Bank | $168 → $145 | Maintains | Buy |
03/06/2023 | 10.58% | Mizuho | $144 → $140 | Maintains | Buy |
03/06/2023 | 9% | Wells Fargo | $154 → $138 | Maintains | Equal-Weight |
03/03/2023 | 20.84% | Credit Suisse | $157 → $153 | Maintains | Outperform |
03/01/2023 | 2.68% | RBC Capital | $114 → $130 | Maintains | Sector Perform |
03/01/2023 | 10.58% | Stephens & Co. | $155 → $140 | Maintains | Equal-Weight |
03/01/2023 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
02/28/2023 | 22.42% | Stephens & Co. | → $155 | Reiterates | → Equal-Weight |
01/24/2023 | 31.9% | UBS | $113 → $167 | Upgrades | Sell → Neutral |
01/09/2023 | 4.26% | Barclays | $115 → $132 | Maintains | Underweight |
01/03/2023 | 21.63% | Wells Fargo | → $154 | Upgrades | Underweight → Equal-Weight |
12/16/2022 | 14.52% | B of A Securities | $120 → $145 | Upgrades | Underperform → Neutral |
12/14/2022 | 13.74% | Mizuho | $126 → $144 | Maintains | Buy |
11/25/2022 | 24% | Credit Suisse | $129 → $157 | Maintains | Outperform |
11/02/2022 | -0.48% | Mizuho | $121 → $126 | Maintains | Buy |
10/27/2022 | -9.96% | SVB Leerink | $98 → $114 | Maintains | Market Perform |
08/24/2022 | -9.17% | SVB Leerink | $111 → $115 | Maintains | Market Perform |
07/28/2022 | -12.33% | SVB Leerink | $103 → $111 | Maintains | Market Perform |
07/27/2022 | -9.96% | RBC Capital | $130 → $114 | Maintains | Sector Perform |
07/15/2022 | -18.65% | SVB Leerink | $108 → $103 | Maintains | Market Perform |
07/12/2022 | -13.12% | Goldman Sachs | $125 → $110 | Maintains | Sell |
07/06/2022 | -28.92% | BMO Capital | → $90 | Downgrades | Market Perform → Underperform |
07/01/2022 | 11.37% | Credit Suisse | $156 → $141 | Maintains | Outperform |
07/01/2022 | -4.43% | Mizuho | $153 → $121 | Maintains | Buy |
06/30/2022 | -14.7% | SVB Leerink | $132 → $108 | Maintains | Market Perform |
06/17/2022 | -9.17% | Loop Capital | → $115 | Initiates Coverage On | → Hold |
05/13/2022 | 4.26% | SVB Leerink | $139 → $132 | Maintains | Market Perform |
05/03/2022 | 20.84% | Mizuho | $164 → $153 | Maintains | Buy |
04/28/2022 | -6.8% | Wells Fargo | $139 → $118 | Maintains | Underweight |
04/27/2022 | 6.63% | Stephens & Co. | $150 → $135 | Maintains | Equal-Weight |
04/27/2022 | 24.79% | Credit Suisse | $172 → $158 | Maintains | Outperform |
04/27/2022 | 2.68% | RBC Capital | $149 → $130 | Maintains | Sector Perform |
03/29/2022 | 9.79% | Wells Fargo | → $139 | Initiates Coverage On | → Underweight |
03/07/2022 | 5.84% | UBS | $124 → $134 | Maintains | Sell |
03/03/2022 | 29.53% | Mizuho | $151 → $164 | Maintains | Buy |
02/28/2022 | — | Seaport Global | Downgrades | Buy → Neutral | |
02/28/2022 | 9.79% | SVB Leerink | $136 → $139 | Maintains | Market Perform |
01/07/2022 | 7.42% | SVB Leerink | $132 → $136 | Maintains | Market Perform |
12/21/2021 | 11.37% | Barclays | $160 → $141 | Maintains | Underweight |
10/29/2021 | 19.26% | Mizuho | $178 → $151 | Maintains | Buy |
10/27/2021 | 4.26% | SVB Leerink | $140 → $132 | Maintains | Market Perform |
09/27/2021 | 10.58% | SVB Leerink | → $140 | Initiates Coverage On | → Market Perform |
09/24/2021 | 7.42% | UBS | → $136 | Initiates Coverage On | → Sell |
09/08/2021 | 18.47% | Goldman Sachs | $155 → $150 | Downgrades | Neutral → Sell |
08/12/2021 | 23.21% | Barclays | $170 → $156 | Downgrades | Overweight → Underweight |
07/28/2021 | 46.12% | Deutsche Bank | $160 → $185 | Maintains | Buy |
07/27/2021 | 34.27% | Barclays | $160 → $170 | Maintains | Overweight |
07/09/2021 | 34.27% | Seaport Global | → $170 | Initiates Coverage On | → Buy |
06/10/2021 | 30.32% | RBC Capital | $160 → $165 | Downgrades | Outperform → Sector Perform |
04/28/2021 | 26.37% | RBC Capital | $150 → $160 | Maintains | Outperform |
04/19/2021 | 26.37% | Deutsche Bank | $145 → $160 | Maintains | Buy |
01/05/2021 | 13.74% | B of A Securities | → $144 | Downgrades | Neutral → Underperform |
09/21/2020 | -9.17% | JP Morgan | $138 → $115 | Downgrades | Neutral → Underweight |
07/29/2020 | -7.59% | Piper Sandler | $113 → $117 | Maintains | Neutral |
07/29/2020 | 10.58% | Credit Suisse | $139 → $140 | Maintains | Outperform |
06/09/2020 | 9% | Barclays | → $138 | Upgrades | Equal-Weight → Overweight |
04/30/2020 | 5.05% | UBS | $150 → $133 | Maintains | Buy |
04/29/2020 | 6.63% | Deutsche Bank | $165 → $135 | Maintains | Buy |
04/28/2020 | 1.1% | Citigroup | $157 → $128 | Maintains | Buy |
04/23/2020 | -10.75% | Piper Sandler | $141 → $113 | Maintains | Neutral |
03/23/2020 | — | B of A Securities | Downgrades | Buy → Neutral | |
03/02/2020 | 22.42% | JP Morgan | $164 → $155 | Maintains | Neutral |
02/28/2020 | 30.32% | Baird | $160 → $165 | Maintains | Outperform |
02/28/2020 | 18.47% | UBS | $158 → $150 | Maintains | Buy |
02/28/2020 | 19.26% | Stephens & Co. | $153 → $151 | Maintains | Equal-Weight |
12/20/2019 | 29.53% | JP Morgan | $159 → $164 | Maintains | Neutral |
10/28/2019 | 9% | Barclays | $145 → $138 | Maintains | Equal-Weight |
07/31/2019 | 15.31% | Morgan Stanley | $135 → $146 | Maintains | Equal-Weight |
04/17/2019 | 2.68% | Barclays | $136 → $130 | Maintains | Equal-Weight |
03/04/2019 | 27.16% | UBS | $156 → $161 | Maintains | Buy |
03/04/2019 | — | JP Morgan | Downgrades | Overweight → Neutral | |
03/01/2019 | 26.37% | Deutsche Bank | $140 → $160 | Maintains | Buy |
03/01/2019 | 7.42% | Barclays | $130 → $136 | Maintains | Equal-Weight |
03/01/2019 | 18.47% | Wells Fargo | $147 → $150 | Maintains | Outperform |
03/01/2019 | 29.53% | Citigroup | $140 → $164 | Maintains | Buy |
02/28/2019 | 14.52% | Baird | $140 → $145 | Maintains | Outperform |
01/14/2019 | — | Stephens & Co. | Initiates Coverage On | → Equal-Weight | |
01/03/2019 | 10.58% | Deutsche Bank | → $140 | Initiates Coverage On | → Buy |
12/14/2018 | — | Goldman Sachs | Downgrades | Neutral → Sell | |
10/29/2018 | 2.68% | Morgan Stanley | $134 → $130 | Maintains | Equal-Weight |
10/29/2018 | 2.68% | Barclays | $135 → $130 | Maintains | Equal-Weight |
10/29/2018 | 10.58% | Citigroup | $145 → $140 | Maintains | Buy |
09/18/2018 | 22.42% | B of A Securities | $128 → $155 | Upgrades | Neutral → Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
09/14/2023 | 16.89% | 康托·菲茨杰拉德 | →$148 | 重申 | 减码→减码 |
07/27/2023 | 33.48% | 瑞士信贷 | $163→$169 | 维护 | 跑赢大盘 |
07/26/2023 | 22.42% | 斯蒂芬斯公司 | →$155 | 重申 | 等重→等重 |
07/11/2023 | 34.27% | 瑞穗 | $150→$170 | 维护 | 买 |
06/02/2023 | 28.74% | B of A证券 | →$163 | 假设 | 中性→购买 |
2023年05月16日 | 9.79% | 高盛 | $124→$139 | 维护 | 卖 |
2023年05月16日 | 18.47% | 瑞穗 | $140→$150 | 维护 | 买 |
05/08/2023 | 21.63% | TD Cowen | $138→$154 | 维护 | 市场表现 |
04/27/2023 | 30.32% | 花旗集团 | $150→$165 | 维护 | 买 |
04/27/2023 | 14.52% | 斯蒂芬斯公司 | $140→$145 | 维护 | 等重 |
04/27/2023 | 22.42% | 德意志银行 | $145→$155 | 维护 | 买 |
04/27/2023 | 20.05% | 加拿大皇家银行资本 | $130→$152 | 维护 | 行业表现 |
04/27/2023 | 28.74% | 瑞士信贷 | $153→$163 | 维护 | 跑赢大盘 |
04/25/2023 | 12.16% | 巴克莱 | $132→$142 | 升级 | 重量不足的→等重 |
04/21/2023 | 12.95% | 康托·菲茨杰拉德 | →$143 | 开始承保 | →减持 |
04/19/2023 | 5.05% | 摩根大通 | →$133 | 开始承保 | →中性 |
03/06/2023 | 14.52% | 德意志银行 | $168→$145 | 维护 | 买 |
03/06/2023 | 10.58% | 瑞穗 | $144→$140 | 维护 | 买 |
03/06/2023 | 9% | 富国银行 | $154→$138 | 维护 | 等重 |
03/03/2023 | 20.84% | 瑞士信贷 | $157→$153 | 维护 | 跑赢大盘 |
03/01/2023 | 2.68% | 加拿大皇家银行资本 | $114→$130 | 维护 | 行业表现 |
03/01/2023 | 10.58% | 斯蒂芬斯公司 | $155→$140 | 维护 | 等重 |
03/01/2023 | - | 沃尔夫研究 | 评级下调 | 超越→同行的表现 | |
02/28/2023 | 22.42% | 斯蒂芬斯公司 | →$155 | 重申 | →等重 |
01/24/2023 | 31.9% | 瑞银集团 | $113→$167 | 升级 | 卖出→中性 |
01/09/2023 | 4.26% | 巴克莱 | $115→$132 | 维护 | 体重不足 |
01/03/2023 | 21.63% | 富国银行 | →$154 | 升级 | 重量不足的→等重 |
12/16/2022 | 14.52% | B of A证券 | $120→$145 | 升级 | 表现不佳的→中性 |
2022年12月14日 | 13.74% | 瑞穗 | $126→$144 | 维护 | 买 |
2022年11月25日 | 百分之二十四 | 瑞士信贷 | $129→$157 | 维护 | 跑赢大盘 |
11/02/2022 | -0.48% | 瑞穗 | $121→$126 | 维护 | 买 |
10/27/2022 | -9.96% | SVB Leerink | $98→$114 | 维护 | 市场表现 |
2022年08月24日 | -9.17% | SVB Leerink | $111→$115 | 维护 | 市场表现 |
07/28/2022 | -12.33% | SVB Leerink | $103→$111 | 维护 | 市场表现 |
07/27/2022 | -9.96% | 加拿大皇家银行资本 | $130→$114 | 维护 | 行业表现 |
07/15/2022 | -18.65% | SVB Leerink | $108→$103 | 维护 | 市场表现 |
07/12/2022 | -13.12% | 高盛 | $125→$110 | 维护 | 卖 |
07/06/2022 | -28.92% | 蒙特利尔银行资本 | →$90 | 评级下调 | 市场表现→表现不佳 |
07/01/2022 | 11.37% | 瑞士信贷 | $156→$141 | 维护 | 跑赢大盘 |
07/01/2022 | -4.43% | 瑞穗 | $153→$121 | 维护 | 买 |
2022/06/30 | -14.7% | SVB Leerink | $132→$108 | 维护 | 市场表现 |
06/17/2022 | -9.17% | 环路资本 | →$115 | 开始承保 | →保留 |
2022年05月13日 | 4.26% | SVB Leerink | $139→$132 | 维护 | 市场表现 |
05/03/2022 | 20.84% | 瑞穗 | $164→$153 | 维护 | 买 |
04/28/2022 | -6.8% | 富国银行 | $139→$118 | 维护 | 体重不足 |
04/27/2022 | 6.63% | 斯蒂芬斯公司 | $150→$135 | 维护 | 等重 |
04/27/2022 | 24.79% | 瑞士信贷 | $172→$158 | 维护 | 跑赢大盘 |
04/27/2022 | 2.68% | 加拿大皇家银行资本 | $149→$130 | 维护 | 行业表现 |
03/29/2022 | 9.79% | 富国银行 | →$139 | 开始承保 | →减持 |
03/07/2022 | 5.84% | 瑞银集团 | $124→$134 | 维护 | 卖 |
03/03/2022 | 29.53% | 瑞穗 | $151→$164 | 维护 | 买 |
02/28/2022 | - | 环球海港 | 评级下调 | 购买→中性 | |
02/28/2022 | 9.79% | SVB Leerink | $136→$139 | 维护 | 市场表现 |
01/07/2022 | 7.42% | SVB Leerink | $132→$136 | 维护 | 市场表现 |
2021/12/21 | 11.37% | 巴克莱 | $160→$141 | 维护 | 体重不足 |
10/29/2021 | 19.26% | 瑞穗 | $178→$151 | 维护 | 买 |
10/27/2021 | 4.26% | SVB Leerink | $140→$132 | 维护 | 市场表现 |
09/27/2021 | 10.58% | SVB Leerink | →$140 | 开始承保 | →市场表现 |
09/24/2021 | 7.42% | 瑞银集团 | →$136 | 开始承保 | →销售 |
09/08/2021 | 18.47% | 高盛 | $155→$150 | 评级下调 | 中性→销售 |
2021/08/12 | 23.21% | 巴克莱 | $170→$156 | 评级下调 | 增持→减持 |
07/28/2021 | 46.12% | 德意志银行 | $160→$185 | 维护 | 买 |
07/27/2021 | 34.27% | 巴克莱 | $160→$170 | 维护 | 超重 |
07/09/2021 | 34.27% | 环球海港 | →$170 | 开始承保 | →购买 |
2021/10/06 | 30.32% | 加拿大皇家银行资本 | $160→$165 | 评级下调 | 跑赢→板块表现 |
04/28/2021 | 26.37% | 加拿大皇家银行资本 | $150→$160 | 维护 | 跑赢大盘 |
04/19/2021 | 26.37% | 德意志银行 | $145→$160 | 维护 | 买 |
01/05/2021 | 13.74% | B of A证券 | →$144 | 评级下调 | 中性→表现不佳 |
2020/09/21 | -9.17% | 摩根大通 | $138→$115 | 评级下调 | 中性→减持 |
07/29/2020 | -7.59% | 派珀·桑德勒 | $113→$117 | 维护 | 中性 |
07/29/2020 | 10.58% | 瑞士信贷 | $139→$140 | 维护 | 跑赢大盘 |
06/09/2020 | 9% | 巴克莱 | →$138 | 升级 | 等重→超重 |
04/30/2020 | 5.05% | 瑞银集团 | $150→$133 | 维护 | 买 |
04/29/2020 | 6.63% | 德意志银行 | $165→$135 | 维护 | 买 |
04/28/2020 | 1.1% | 花旗集团 | $157→$128 | 维护 | 买 |
04/23/2020 | -10.75% | 派珀·桑德勒 | $141→$113 | 维护 | 中性 |
03/23/2020 | - | B of A证券 | 评级下调 | 购买→中性 | |
03/02/2020 | 22.42% | 摩根大通 | $164→$155 | 维护 | 中性 |
02/28/2020 | 30.32% | 贝尔德 | $160→$165 | 维护 | 跑赢大盘 |
02/28/2020 | 18.47% | 瑞银集团 | $158→$150 | 维护 | 买 |
02/28/2020 | 19.26% | 斯蒂芬斯公司 | $153→$151 | 维护 | 等重 |
2019年12月20日 | 29.53% | 摩根大通 | $159→$164 | 维护 | 中性 |
2019年10月28日 | 9% | 巴克莱 | $145→$138 | 维护 | 等重 |
2019年07月31日 | 15.31% | 摩根士丹利 | $135→$146 | 维护 | 等重 |
2019/04/17 | 2.68% | 巴克莱 | $136→$130 | 维护 | 等重 |
2019/03/04 | 27.16% | 瑞银集团 | $156→$161 | 维护 | 买 |
2019/03/04 | - | 摩根大通 | 评级下调 | 超重→中性 | |
2019年03月01日 | 26.37% | 德意志银行 | $140→$160 | 维护 | 买 |
2019年03月01日 | 7.42% | 巴克莱 | $130→$136 | 维护 | 等重 |
2019年03月01日 | 18.47% | 富国银行 | $147→$150 | 维护 | 跑赢大盘 |
2019年03月01日 | 29.53% | 花旗集团 | $140→$164 | 维护 | 买 |
2019年02月28日 | 14.52% | 贝尔德 | $140→$145 | 维护 | 跑赢大盘 |
2019年01月14日 | - | 斯蒂芬斯公司 | 开始承保 | →等重 | |
2019年03月01日 | 10.58% | 德意志银行 | →$140 | 开始承保 | →购买 |
2018年12月14日 | - | 高盛 | 评级下调 | 中性→销售 | |
2018年10月29日 | 2.68% | 摩根士丹利 | $134→$130 | 维护 | 等重 |
2018年10月29日 | 2.68% | 巴克莱 | $135→$130 | 维护 | 等重 |
2018年10月29日 | 10.58% | 花旗集团 | $145→$140 | 维护 | 买 |
2018年09月18日 | 22.42% | B of A证券 | $128→$155 | 升级 | 中性→购买 |
What is the target price for Universal Health Servs (UHS)?
Universal Health Serv(UHS)的目标价格是多少?
The latest price target for Universal Health Servs (NYSE: UHS) was reported by Cantor Fitzgerald on September 14, 2023. The analyst firm set a price target for $148.00 expecting UHS to rise to within 12 months (a possible 16.89% upside). 32 analyst firms have reported ratings in the last year.
Cantor Fitzgerald于2023年9月14日报道了Universal Health Serv(纽约证券交易所代码:UHS)的最新目标价。这家分析公司将目标价定为148.00美元,预计UHS将在12个月内上涨至16.89%(可能上涨16.89%)。去年有32家分析公司公布了评级。
What is the most recent analyst rating for Universal Health Servs (UHS)?
分析师对Universal Health Serv(UHS)的最新评级是多少?
The latest analyst rating for Universal Health Servs (NYSE: UHS) was provided by Cantor Fitzgerald, and Universal Health Servs reiterated their underweight rating.
环球健康服务公司(纽约证券交易所代码:UHS)的最新分析师评级由Cantor Fitzgerald提供,环球健康服务公司重申其减持评级。
When is the next analyst rating going to be posted or updated for Universal Health Servs (UHS)?
Universal Health Serv(UHS)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Universal Health Servs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Universal Health Servs was filed on September 14, 2023 so you should expect the next rating to be made available sometime around September 14, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与Universal Health Serv的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Universal Health Serv的上一次评级是在2023年9月14日提交的,因此您应该预计下一次评级将在2024年9月14日左右提供。
Is the Analyst Rating Universal Health Servs (UHS) correct?
分析师对Universal Health Serv(UHS)的评级正确吗?
While ratings are subjective and will change, the latest Universal Health Servs (UHS) rating was a reiterated with a price target of $0.00 to $148.00. The current price Universal Health Servs (UHS) is trading at is $126.61, which is within the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的Universal Health Serv(UHS)评级被重申,目标价在0.00美元至148.00美元之间。Universal Health Serv目前的交易价格为126.61美元,在分析师的预测范围内。